These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7629420)

  • 1. Neuron-specific enolase (NSE) in serum. Comparison of monoclonal versus polyclonal assay based on 392 blood samples.
    Drivsholm L; Osterlind K; Cooper EH; Purves DA
    Int J Biol Markers; 1995; 10(1):1-4. PubMed ID: 7629420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Basic and clinical evaluation of neuron-specific enolase (NSE) RIA kit].
    Katsuragi M; Ichiya Y; Kuwabara Y; Wada M; Ayabe Z; Baba H; Matsuura K
    Kaku Igaku; 1985 Oct; 22(10):1569-74. PubMed ID: 3005726
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancer.
    Body JJ; Paesmans M; Sculier JP; Dabouis G; Bureau G; Libert P; Berchier MC; Raymakers N; Klastersky J
    Clin Chem; 1992 May; 38(5):748-51. PubMed ID: 1316245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer.
    O'Shea P; Cassidy M; Freaney R; McCarthy P; Fennelly J
    Ir J Med Sci; 1995 Jan; 164(1):31-6. PubMed ID: 7890531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase.
    Giovanella L; Ceriani L; Bandera M; Garancini S
    Int J Biol Markers; 2001; 16(1):50-5. PubMed ID: 11288956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of neuron specific enolase (NSE) radioimmunoassay kit].
    Kozakai K; Takano M; Abe K; Tanaka N; Sato K; Maruyama Y; Noguchi M; Kaneko I; Sasaki Y; Tsujino D
    Kaku Igaku; 1986 Jan; 23(1):85-91. PubMed ID: 3009940
    [No Abstract]   [Full Text] [Related]  

  • 7. Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay.
    Muley T; Ebert W; Stieber P; Raith H; Holdenrieder S; Nagel D; Fürst H; Roth HJ; Luthe H; Blijenberg BG; Gurr E; Uhl W; von Pawel J; Drings P
    Clin Chem Lab Med; 2003 Jan; 41(1):95-103. PubMed ID: 12636057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
    Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
    Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical value of measurement of serum creatine kinase BB and neuron specific enolase for small cell lung cancer].
    Zhou J; Xiong Q
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):90-3. PubMed ID: 7657349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer.
    Pinson P; Joos G; Watripont P; Brusselle G; Pauwels R
    Respiration; 1997; 64(1):102-7. PubMed ID: 9044484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.
    Yamaguchi K; Aoyagi K; Urakami K; Fukutani T; Maki N; Yamamoto S; Otsubo K; Miyake Y; Kodama T
    Jpn J Cancer Res; 1995 Jul; 86(7):698-705. PubMed ID: 7559089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cut-off levels of NSE to differentiate SCLC from NSCLC.
    Satoh H; Ishikawa H; Kurishima K; Yamashita YT; Ohtsuka M; Sekizawa K
    Oncol Rep; 2002; 9(3):581-3. PubMed ID: 11956631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer].
    Yano H; Hino M; Nishiwaki Y; Kodama T; Hayashibe A; Kudo H; Inoue Y; Nishiyama Y; Sone Y; Oshima T
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):77-83. PubMed ID: 3026257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
    Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
    Br J Cancer; 1994 Oct; 70(4):759-61. PubMed ID: 7917935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basic and clinical studies of measurement of neuron specific enolase (NSE) using pharmacia NSE RIA kit].
    Koizumi M; Endo K; Nakajima K; Sakahara H; Nakashima T; Ohta H; Kawamura Y; Matsui Y; Torizuka K
    Kaku Igaku; 1986 Feb; 23(2):173-9. PubMed ID: 3712856
    [No Abstract]   [Full Text] [Related]  

  • 16. Fucosyl-GM1 in small-cell lung cancer. A comparison with the tumour marker neuron-specific enolase.
    Drivsholm L; Vangsted A; Pallesen T; Hansen M; Dombernowsky P; Hirsch F; Hansen HH
    Ann Oncol; 1994 Sep; 5(7):623-6. PubMed ID: 7993838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The usefulness of serum neuron-specific enolase in the clinical management of small-cell lung carcinoma].
    Sánchez de Cos Escuín J; Masa Jiménez F; Disdier Vicente C; de la Cruz Ríos JL; Vergara Fiordia C; Domínguez Retortillo C; Fuentes Otero F
    Arch Bronconeumol; 1994 Oct; 30(8):375-80. PubMed ID: 7987543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum NSE, CEA, CT, CA 15-3 levels in human lung cancer.
    Nutini S; Cappelli G; Benucci A; Catalani C; Nozzoli F
    Int J Biol Markers; 1990; 5(4):198-202. PubMed ID: 1965544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of serum neuron-specific enolase levels in patients with lung cancer].
    Mori Y; Hoshi H; Jinnouchi S; Harada K; Onoe K; Nagamachi S; Ozawa M; Watanabe K; Tawara Y
    Radioisotopes; 1987 Feb; 36(2):78-80. PubMed ID: 3033753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
    Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
    Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.